HeLa cells and iPSC‐MNs expressing mutated FUS, as well as ALS patients’ fibroblasts and spinal cord MNs are vulnerable to Hsp90 inhibition and show defective induction of DYRK3. This evidence concerns the gene HSP90AB1 and amyotrophic lateral sclerosis.